Table 2.
Before Control |
After Control |
|||||
---|---|---|---|---|---|---|
dN | dS | dN/dS | dN | dS | dN/dS | |
Human–macaquea | ||||||
Promoter methylation | 0.2052*** | 0.0798*** | 0.1928*** | 0.1434*** | 0.0009 | 0.1601*** |
Gene body methylation | −0.0975*** | −0.0872*** | −0.0803*** | −0.0607*** | −0.0121 | −0.0718*** |
Human–mouseb | ||||||
Promoter methylation | 0.268*** | 0.1453*** | 0.2304*** | 0.1907*** | 0.0329* | 0.1827*** |
Gene body methylation | −0.096*** | −0.0768*** | −0.0793*** | −0.0289* | 0.025 | −0.0452*** |
Note.—The ten confounding factors are NTF, NmiR, protein connectivity, expression level, tissue specificity, UTR length, intron length, intron number, solvent accessibility, and disorder content.
aThe analysis was based on 5,128 human genes and their macaque orthologs.
bThe analysis was based on 5,357 human genes and their mouse orthologs.
*P < 0.05 and ***P < 0.001.